The manufacturer of the experimental drug that cancer sufferer Vicky Phelan is using has no plans to fund a drug trial in Ireland.
Manufacturer MSD said it needed to do a broader and more comprehensive trial than what was possible in Ireland. It said this was needed in order to get regulatory approval for the drug in the EU.
Phelan, who exposed the CervicalCheck controversy earlier this year, received an experimental drug called Pembro (Pembrolizumab),...
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Get a Business Account for you and your team